Because of the increasing prevalence of peripheral artery diseases, venus thromboembolism, coronary diseases, and other conditions, the global clot management devices market is expected to grow steadily. The ever-expanding pool of high-risk geriatric population also drives the market’s pace. There has been a continuous growth in demand for embolectomy devices due to an evolution in the nature of clot management procedures and growing awareness among the patient population and healthcare professionals regarding the proven benefits of novel devices.
Furthermore, the recommendation by the USFDA for the use of clot retrieval systems as the basic therapy for stroke also facilitates the demand for these devices. Percutaneous thrombectomy currently leads the clot management device market with a market share of over 30%. Additionally, the neurovascular embolectomy segment will witness the fastest market growth throughout the forecast period. Perpetual investments and the technological development of these devices, making them more precise and cost-effective, drive this segment.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Hospitals and diagnostic centers are the major end-users of clot management devices. Hospitals are the most common users of clot management devices, accounting for more than 75% of revenue in 2017. A greater number of patients walking through hospitals and higher affordability are the key factors contributing to the dominance of this segment. Furthermore, better reimbursements also drive the growth of the hospital segment in the global clot management devices market. On the other hand, the diagnostics segment will register the fastest growth during the forecast period.
Based on regional demarcation, North America is anticipated to dominate the global market for clot management devices. The high prevalence of peripheral vascular and cardiovascular diseases, the greater existence of high-risk geriatric populations, the evolved scenario, and the domicile of major market players in the region all contribute to the dominance of the North American market. This market is mainly driven by technological innovation, so a constant influx of funding for research and development is implemented by major market players. Some of the key players in the global clot management device market include
The global clot management devices market is segmented on the following basis:
Product Type
- Neurovascular Embolectomy Devices
- Percutaneous thrombectomy devices
- Embolectomy Balloon Catheters
- Catheter-Directed Thrombolysis (CDT) Devices
- Inferior Vena Cava Filters (IVCF)
End-use
- Hospitals
- Diagnostic Centers and Specialty Clinics
Geography
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Key players identified for the clot management devices market include but are not limited to:
Medtronic, vascular, Teleflex, Boston Scientific Corporation, Vascular Solutions, Inc., Edwards Lifesciences, and others
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
This report offers the following:
- An analysis of several techniques, test types, and regions that would provide a clear understanding of the ongoing and future trends in the global clot management devices market
- Assessment of market dynamics, such as drivers, restraints, and opportunities prevalent in the market
- Quantitative assessment of the current market size and future estimations for the period from 2016 to 2026, along with CAGRs for the period from 2018 to 2026
- Company profiles that will highlight key information about the imperative players operating in the global clot management devices market
